Literature DB >> 15520847

How does blood glucose control with insulin save lives in intensive care?

Greet Van den Berghe1.   

Abstract

Patients requiring prolonged intensive care are at high risk for multiple organ failure and death. Insulin resistance and hyperglycemia accompany critical illness, and the severity of this "diabetes of stress" reflects the risk of death. Recently it was shown that preventing hyperglycemia with insulin substantially improves outcome of critical illness. This article examines some potential mechanisms underlying prevention of glucose toxicity as well as the effects of insulin independent of glucose control. Unraveling the molecular mechanisms will provide new insights into the pathogenesis of multiple organ failure and open avenues for novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520847      PMCID: PMC524243          DOI: 10.1172/JCI23506

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  88 in total

1.  Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells.

Authors:  Monica Montagnani; Inga Golovchenko; Injune Kim; Gou Young Koh; Marc L Goalstone; Ameya N Mundhekar; Mette Johansen; Dennis F Kucik; Michael J Quon; Boris Draznin
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

Review 2.  Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels.

Authors:  M P Fink; T W Evans
Journal:  Intensive Care Med       Date:  2002-02-08       Impact factor: 17.440

Review 3.  Alterations in fuel metabolism in critical illness: hyperglycaemia.

Authors:  B A Mizock
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2001-12       Impact factor: 4.690

Review 4.  Changes in the concentration and composition of plasma lipoproteins during the acute phase response.

Authors:  Yvon A Carpentier; Olivier Scruel
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-03       Impact factor: 4.294

5.  Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity.

Authors:  Elliott D Crouser; Mark W Julian; Dorottya V Blaho; Douglas R Pfeiffer
Journal:  Crit Care Med       Date:  2002-02       Impact factor: 7.598

6.  Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation.

Authors:  Feng Gao; Erhe Gao; Tian-Li Yue; Eliot H Ohlstein; Bernard L Lopez; Theodore A Christopher; Xin-Liang Ma
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

7.  Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.

Authors:  A C Mavrommatis; T Theodoridis; M Economou; A Kotanidou; M El Ali; V Christopoulou-Kokkinou; S G Zakynthinos
Journal:  Intensive Care Med       Date:  2001-11-10       Impact factor: 17.440

8.  A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response.

Authors:  Frank Weekers; Erik Van Herck; Willy Coopmans; Marina Michalaki; Cyril Y Bowers; Johannes D Veldhuis; Greet Van den Berghe
Journal:  Endocrinology       Date:  2002-03       Impact factor: 4.736

9.  Oxidative stress and programmed cell death in diabetic neuropathy.

Authors:  Andrea M Vincent; Michael Brownlee; James W Russell
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

Review 10.  Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings.

Authors:  André Marette
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-07       Impact factor: 4.294

View more
  111 in total

1.  Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit.

Authors:  Kupper A Wintergerst; Michael B Foster; Janice E Sullivan; Charles R Woods
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 2.  Stress hyperglycemia in pediatric critical illness: the intensive care unit adds to the stress!

Authors:  Vijay Srinivasan
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 3.  [Postoperative wound infections. Pathophysiology, risk factors and preventive concepts].

Authors:  T Hachenberg; M Sentürk; O Jannasch; H Lippert
Journal:  Anaesthesist       Date:  2010-09       Impact factor: 1.041

4.  Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  E H Baker; C H Janaway; B J Philips; A L Brennan; D L Baines; D M Wood; P W Jones
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

5.  Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill?

Authors:  P E Cryer
Journal:  Diabetologia       Date:  2006-08       Impact factor: 10.122

Review 6.  Vasculotoxic effects of insulin and its role in atherosclerosis: what is the evidence?

Authors:  Shailesh Nandish; Oscar Bailon; Jamison Wyatt; John Smith; Adrienne Stevens; Mike Lujan; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

Review 7.  Intensive insulin therapy in the ICU--reconciling the evidence.

Authors:  Greet Van den Berghe
Journal:  Nat Rev Endocrinol       Date:  2012-02-07       Impact factor: 43.330

8.  Intensive insulin therapy in the intensive care unit.

Authors:  Greet Van den Berghe; Dieter Mesotten; Ilse Vanhorebeek
Journal:  CMAJ       Date:  2009-03-24       Impact factor: 8.262

Review 9.  New insights into insulin: The anti-inflammatory effect and its clinical relevance.

Authors:  Qiang Sun; Jia Li; Feng Gao
Journal:  World J Diabetes       Date:  2014-04-15

10.  Intensive insulin therapy protects the endothelium of critically ill patients.

Authors:  Lies Langouche; Ilse Vanhorebeek; Dirk Vlasselaers; Sarah Vander Perre; Pieter J Wouters; Kristin Skogstrand; Troels K Hansen; Greet Van den Berghe
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.